+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global CRISPR Market 2021-2028

  • PDF Icon

    Report

  • 245 Pages
  • September 2021
  • Region: Global
  • Triton Market Research
  • ID: 5116989
According to This report, the global CRISPR market is anticipated to display growth at a CAGR of 20.38% through the projected period of 2021-2028.





Factors such as growing lifestyle-oriented diseases and the surging prevalence of genetic diseases are widening the scope of the CRISPR market globally. Additionally, the advancements in gene-based therapy in the agriculture sector, coupled with the increased need for clinical trials, are opening new avenues for the global market over the forecasted period.

In contrast, the rising ethical concerns relating to technology use and the absence of healthcare budgets in developing nations hamper the overall development of the CRISPR market.

Regional Outlook

The global CRISPR market covers North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa regions.

The Asia-Pacific is estimated to observe the fastest growth in the CRISPR market over the considered phase. This growth can be attributed to the continuous research and development activities across India and China. Moreover, these countries have well-developed agriculture research facilities to develop effective and productive crops. Furthermore, the growing reliance on non-vegetarian foods, such as red meat and seafood, contributes to the market’s development over the projected phase. Above all, the rising demand for aquaculture predominantly drives the growth of the CRISPR market across the APAC region.

Competitive Outlook

The prominent companies in the CRISPR market are Integrated DNA Technologies, Intellia therapeutics, Horizon Discovery Group, Precision Biosciences, Genscript, Novartis International AG, Editas Medicine, Caribou Biosciences Inc, Synthego Corporation, OriGene Technologies Inc, Cellectis Bioresearch SAS, CRISPR therapeutics AG, Addgene, New England Biolabs, and Lonza Group Ltd.
Novartis International AG is among the leading pharmaceutical company having a solid presence in biopharmaceutical segments. It is involved in the research, development, and marketing of medicines, eye care products, and generic pharma products. Its comprehensive product line includes CAR-T cell therapy, revolutionary immunotherapy that utilizes specifically altered cells from the immune system to fight cancer. The company sells its products in more than 155 countries.
Frequently Asked Questions about the Global Crispr Market

What is the estimated value of the Global Crispr Market?

The Global Crispr Market was estimated to be valued at $1.2 Billion in 2021.

What is the growth rate of the Global Crispr Market?

The growth rate of the Global Crispr Market is 20.3%, with an estimated value of $4.5 Billion by 2028.

What is the forecasted size of the Global Crispr Market?

The Global Crispr Market is estimated to be worth $4.5 Billion by 2028.

Who are the key companies in the Global Crispr Market?

Key companies in the Global Crispr Market include Addgene, Caribou Biosciences Inc, Cellectis Bioresearch Sas, Crispr Therapeutics AG, Editas Medicine, Genscript, Horizon Discovery Group, Integrated Dna Technologies and Lonza Group Ltd.

Table of Contents

1. Global CRISPR Market - Summary
2. Industry Outlook
2.1. Impact of Covid-19 on CRISPR Market
2.2. Key Insights
2.2.1. Industrial Biotech is the Fastest Growing Industry Vertical
2.2.2. Rewriting of Genetic Disorders Through Genome Surgery
2.2.3. Increasing Usage of Prospective Applications of CRISPR Technology
2.3. Porter’S Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Vendor Scorecard
2.6. Legal & Regulatory Outlook
2.7. Patent Outlook
2.8. Funding Outlook
2.9. Key Impact Analysis
2.9.1. Cost
2.9.2. Accuracy
2.9.3. Easy to Use
2.10. Key Market Strategies
2.10.1. Acquisitions
2.10.2. Product Launches
2.10.3. Contracts & Partnerships
2.10.4. Business Expansions & Divestitures
2.11. Market Drivers
2.11.1. Growing Lifestyle-Oriented Diseases
2.11.2. Surging Prevalence of Genetic Diseases
2.12. Market Challenges
2.12.1. Growing Ethical Issues Regarding Technology Use
2.12.2. Likely Misuse of Gene-Editing Tool
2.12.3. Absence of Healthcare Budgets in Developing Countries
2.13. Market Opportunities
2.13.1. Advancements in Gene-Based Therapy in the Agricultural Sector
2.13.2. Increased Need for Clinical Trials
2.13.3. Rise in Awareness About Gene Therapeutics
3. Global CRISPR Market Outlook - by Product
3.1. Plasmids
3.2. Vectors
3.3. Proteins
3.4. Designing Tools
3.5. Grna
3.6. Control Kits
3.7. Library
3.8. Other Products
4. Global CRISPR Market Outlook - by Application
4.1. Genome Editing/Genetic Engineering
4.2. CRISPR Plasmid
4.3. Human Stem Cells
4.4. Grna Database/Gene Library
4.5. Cell Line Engineering
5. Global CRISPR Market Outlook - by Industry Verticals
5.1. Therapeutics and Drug Discovery
5.2. Biological Research
5.3. Agricultural Biotech
5.4. Industrial Biotech
6. Global CRISPR Market – Regional Outlook
6.1. North America
6.1.1. Market by Product
6.1.2. Market by Application
6.1.3. Market by Industry Verticals
6.1.4. Country Analysis
6.1.4.1. United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Product
6.2.2. Market by Application
6.2.3. Market by Industry Verticals
6.2.4. Country Analysis
6.2.4.1. United Kingdom
6.2.4.2. Germany
6.2.4.3. France
6.2.4.4. Spain
6.2.4.5. Italy
6.2.4.6. Russia
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Product
6.3.2. Market by Application
6.3.3. Market by Industry Verticals
6.3.4. Country Analysis
6.3.4.1. China
6.3.4.2. Japan
6.3.4.3. India
6.3.4.4. South Korea
6.3.4.5. Asean Countries
6.3.4.6. Australia & New Zealand
6.3.4.7. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Market by Product
6.4.2. Market by Application
6.4.3. Market by Industry Verticals
6.4.4. Country Analysis
6.4.4.1. Brazil
6.4.4.2. Mexico
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Product
6.5.2. Market by Application
6.5.3. Market by Industry Verticals
6.5.4. Country Analysis
6.5.4.1. United Arab Emirates
6.5.4.2. Saudi Arabia
6.5.4.3. Turkey
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa
7. Competitive Landscape
7.1. Addgene
7.2. Caribou Biosciences Inc
7.3. Cellectis Bioresearch Sas
7.4. CRISPR Therapeutics AG
7.5. Editas Medicine
7.6. Genscript
7.7. Horizon Discovery Group
7.8. Integrated Dna Technologies
7.9. Intellia Therapeutics
7.10. Lonza Group Ltd
7.11. New England Biolabs
7.12. Novartis International AG
7.13. Origene Technologies Inc
7.14. Precision Biosciences
7.15. Synthego Corporation
8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.2. Sources of Data
8.3. Research Methodology
List of Tables
Table 1: Global CRISPR Market, by Geography, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Regulatory Framework
Table 4: Funding Outlook of Public Companies
Table 5: Funding Outlook of Private Companies
Table 6: Funding Outlook of Government Organizations
Table 7: Global CRISPR Market, by Product, 2021-2028 (In $ Million)
Table 8: Global CRISPR Market, by Application, 2021-2028 (In $ Million)
Table 9: Global CRISPR Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 10: Global CRISPR Market, by Geography, 2021-2028 (In $ Million)
Table 11: North America CRISPR Market, by Country, 2021-2028 (In $ Million)
Table 12: North America CRISPR Market, by Product, 2021-2028 (In $ Million)
Table 13: North America CRISPR Market, by Application, 2021-2028 (In $ Million)
Table 14: North America CRISPR Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 15: Europe CRISPR Market, by Country, 2021-2028 (In $ Million)
Table 16: Europe CRISPR Market, by Product, 2021-2028 (In $ Million)
Table 17: Europe CRISPR Market, by Application, 2021-2028 (In $ Million)
Table 18: Europe CRISPR Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 19: Asia-Pacific CRISPR Market, by Country, 2021-2028 (In $ Million)
Table 20: Asia-Pacific CRISPR Market, by Product, 2021-2028 (In $ Million)
Table 21: Asia-Pacific CRISPR Market, by Application, 2021-2028 (In $ Million)
Table 22: Asia-Pacific CRISPR Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 23: Latin America CRISPR Market, by Country, 2021-2028 (In $ Million)
Table 24: Latin America CRISPR Market, by Product, 2021-2028 (In $ Million)
Table 25: Latin America CRISPR Market, by Application, 2021-2028 (In $ Million)
Table 26: Latin America CRISPR Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 27: Middle East and Africa CRISPR Market, by Country, 2021-2028 (In $ Million)
Table 28: Middle East and Africa CRISPR Market, by Product, 2021-2028 (In $ Million)
Table 29: Middle East and Africa CRISPR Market, by Application, 2021-2028 (In $ Million)
Table 30: Middle East and Africa CRISPR Market, by Industry Verticals, 2021-2028 (In $ Million)
List of Figures
Figure 1: Market Attractiveness Index
Figure 2: Funding Scenario Share, by Type of Companies/Organization
Figure 3: Key Impact Analysis
Figure 4: Global CRISPR Market, by Product, 2020 & 2028 (In %)
Figure 5: Global CRISPR Market, by Plasmids, 2021-2028 (In $ Million)
Figure 6: Global CRISPR Market, by Vectors, 2021-2028 (In $ Million)
Figure 7: Global CRISPR Market, by Proteins, 2021-2028 (In $ Million)
Figure 8: Global CRISPR Market, by Designing Tools, 2021-2028 (In $ Million)
Figure 9: Global CRISPR Market, by Grna, 2021-2028 (In $ Million)
Figure 10: Global CRISPR Market, by Control Kits, 2021-2028 (In $ Million)
Figure 11: Global CRISPR Market, by Library, 2021-2028 (In $ Million)
Figure 12: Global CRISPR Market, by Other Products, 2021-2028 (In $ Million)
Figure 13: Global CRISPR Market, by Application, 2020 & 2028 (In %)
Figure 14: Global CRISPR Market, by Genome Editing/Genetic Engineering, 2021-2028 (In $ Million)
Figure 15: Global CRISPR Market, by CRISPR Plasmid, 2021-2028 (In $ Million)
Figure 16: Global CRISPR Market, by Human Stem Cells, 2021-2028 (In $ Million)
Figure 17: Global CRISPR Market, by Grna Database/Gene Library, 2021-2028 (In $ Million)
Figure 18: Global CRISPR Market, by Cell Line Engineering, 2021-2028 (In $ Million)
Figure 19: Global CRISPR Market, by Industry Verticals, 2020 & 2028 (In %)
Figure 20: Global CRISPR Market, by Therapeutics and Drug Discovery, 2021-2028 (In $ Million)
Figure 21: Global CRISPR Market, by Biological Research, 2021-2028 (In $ Million)
Figure 22: Global CRISPR Market, by Agricultural Biotech, 2021-2028 (In $ Million)
Figure 23: Global CRISPR Market, by Industrial Biotech, 2021-2028 (In $ Million)
Figure 24: Global CRISPR Market, Regional Outlook, 2020 & 2028 (In %)
Figure 25: United States CRISPR Market 2021-2028 (In $ Million)
Figure 26: Canada CRISPR Market 2021-2028 (In $ Million)
Figure 27: United Kingdom CRISPR Market 2021-2028 (In $ Million)
Figure 28: Germany CRISPR Market 2021-2028 (In $ Million)
Figure 29: France CRISPR Market 2021-2028 (In $ Million)
Figure 30: Spain CRISPR Market 2021-2028 (In $ Million)
Figure 31: Italy CRISPR Market 2021-2028 (In $ Million)
Figure 32: Russia CRISPR Market 2021-2028 (In $ Million)
Figure 33: Rest of Europe CRISPR Market 2021-2028 (In $ Million)
Figure 34: China CRISPR Market 2021-2028 (In $ Million)
Figure 35: Japan CRISPR Market 2021-2028 (In $ Million)
Figure 36: India CRISPR Market 2021-2028 (In $ Million)
Figure 37: South Korea CRISPR Market 2021-2028 (In $ Million)
Figure 38: Asean Countries CRISPR Market 2021-2028 (In $ Million)
Figure 39: Australia & New Zealand CRISPR Market 2021-2028 (In $ Million)
Figure 40: Rest of Asia-Pacific CRISPR Market 2021-2028 (In $ Million)
Figure 41: Brazil CRISPR Market 2021-2028 (In $ Million)
Figure 42: Mexico CRISPR Market 2021-2028 (In $ Million)
Figure 43: Rest of Latin America CRISPR Market 2021-2028 (In $ Million)
Figure 44: United Arab Emirates CRISPR Market 2021-2028 (In $ Million)
Figure 45: Saudi Arabia CRISPR Market 2021-2028 (In $ Million)
Figure 46: Turkey CRISPR Market 2021-2028 (In $ Million)
Figure 47: South Africa CRISPR Market 2021-2028 (In $ Million)
Figure 48: Rest of Middle East & Africa CRISPR Market 2021-2028 (In $ Million)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Addgene
  • Caribou Biosciences Inc
  • Cellectis Bioresearch Sas
  • Crispr Therapeutics AG
  • Editas Medicine
  • Genscript
  • Horizon Discovery Group
  • Integrated Dna Technologies
  • Intellia Therapeutics
  • Lonza Group Ltd
  • New England Biolabs
  • Novartis International AG
  • Origene Technologies Inc
  • Precision Biosciences
  • Synthego Corporation

Methodology

Loading
LOADING...